小脑变性相关蛋白2抗体

英文名称    CDR2    

中文名称    小脑变性相关蛋白2抗体    

别    名    CDR 2; CDR 62; CDR2; CDR2_HUMAN; CDR62; Cerebellar degeneration related protein 2; Cerebellar degeneration related protein; Cerebellar degeneration-related protein 2; Major Yo paraneoplastic antigen; Paraneoplastic cerebellar degeneration associated antigen; Paraneoplastic cerebellar degeneration-associated antigen; PCD 17; PCD17; Yo antibody; Yo paraneoplastic antigen.    

说 明 书    0.2ml      

研究领域    肿瘤  细胞生物  免疫学  肿瘤细胞生物标志物      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Dog, Cow, Horse,     

产品应用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500小脑变性相关蛋白2抗体 （石蜡切片需做抗原修复） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    52kDa    

性    状    Lyophilized or Liquid    

浓    度    1mg/1ml    

免 疫 原    KLH conjugated synthetic peptide derived from human CDR2/PCD17    

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

小脑变性相关蛋白2抗体产品介绍    background:

CDR2 (cerebellar degeneration-related protein 2), also referred to as Yo or CDR62, is a 545 amino acid protein that is associated with the development of paraneoplastic cerebellar degeneration (PCD). PCD, an immune-mediated syndrome, belongs to a heterogeneous group of rare paraneoplastic neurologic disorders affecting the neurological system. PCD is characterized by subacute cerebellar ataxia and occurs mainly in patients with ovarian, uterine, fallopian tube or breast cancer. Patients with ovarian or breast cancer develop an immune response against cancer cell-expressed CDR2 and Purkinje neuron-expressed CDR2. The presence of the anti-CDR2 antibody in patients with PCD symptoms warrants an aggressive approach to diagnosis and treatment of the underlying cancer.    

小脑变性相关蛋白2抗体

hz-8439R BEND6  BEND6蛋白抗体

hz-8440R c-ABL1/2(Tyr393/429)  磷酸化非受体酪氨酸激酶c-Abl抗体

hz-8441R NF-κB p105/p50(Phospho-Ser373)  磷酸化细胞核因子p50/k基因结合核因子抗体

hz-8442R phospho-C-Myc(Thr373)  磷酸化致癌基因C-Myc抗体

hz-8443R Lin28  RNA结合蛋白LIN28抗体

hz-8444R Phospho-BRCA1(Ser988)  磷酸化乳腺癌易感基因1抗体

hz-8445R phospho-Cdc25B (Ser149)  磷酸化细胞分裂周期蛋白25B抗体

hz-8446R phospho-GluR1(Ser849)  磷酸化谷氨酸受体1抗体

hz-8447R ZNF471  锌指蛋白471抗体

hz-8448R Phospho-NMDAR2B (Tyr1474)  磷酸化谷氨酸受体2B抗体

hz-8449R phospho-ATF2 (Thr53)  磷酸化活化复制因子2抗体

hz-8450R phospho-ATF2 (Thr55)  磷酸化活化复制因子2抗体

hz-8451R phospho-HNF4 (Ser304)  磷酸化肝细胞核因子4α抗体

hz-8452R SNAPC3  SNAPC3蛋白抗体

hz-8453R phospho-Tau protein(Thr181)  磷酸化微管相关蛋白抗体

hz-8454R phospho-GluR1(Ser836)  磷酸化谷氨酸受体1抗体

hz-8455R SCNN1D/δENaC  上皮钠离子通道蛋白D抗体

hz-8456R Phospho-TrkA (Ser791)  磷酸化酪氨酸激酶A抗体

hz-8457R AGPHD1  氨基糖苷类磷酸结构域蛋白抗体

hz-8458R PTRF  RNA聚合酶1和转录释放因子抗体

hz-8459R FKSG14/Centromere protein K  着丝粒蛋白K

hz-8460R FNDC1  Ⅲ型纤维连接蛋白域蛋白1

hz-8461R MX2/MXB  干扰素诱导GTP结合蛋白MX2抗体

hz-8462R APLP2  淀粉样蛋白β前体样蛋白2抗体

hz-8463R ZNF804A  锌指蛋白804A抗体

hz-8464R SENP5  泛素相关修饰蛋白特异性蛋白酶5抗体

hz-8465R APLP1  淀粉样蛋白β前体样蛋白1抗体

hz-8466R FbxL12  FBXL12蛋白抗体

hz-8467R FBXL3  FBXL3蛋白抗体

hz-8468R FBXL5  FBXL5蛋白抗体

hz-8469R FBXL17  FBXL17蛋白抗体

hz-8470R FBXO36  FBXO36 F-box蛋白相关蛋白36抗体

hz-8471R FBXO33  F-box蛋白相关蛋白33抗体

hz-8472R FBXO11  F-box蛋白相关蛋白11抗体